A Phase II Study of KUC-7483 in Patients With Overactive Bladder

A Study of YM178 in Patients With Symptomatic Overactive Bladder

NCT00527033 ·Status: COMPLETED ·Phase: PHASE2

Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder.

NCT03175029 ·Status: COMPLETED ·Phase: PHASE2

Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan

NCT00212706 ·Status: COMPLETED ·Phase: PHASE2

A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder.

NCT00798434 ·Status: COMPLETED ·Phase: PHASE4

Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder.

NCT00658684 ·Status: COMPLETED ·Phase: PHASE3

Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan

NCT00212732 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder

NCT00966004 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity

NCT00335660 ·Status: TERMINATED ·Phase: PHASE2

A Study of YM178 in Subjects With Symptoms of Overactive Bladder

NCT01043666 ·Status: COMPLETED ·Phase: PHASE3

Local Anesthetic Treatments for Overactive Bladder

NCT00427648 ·Status: TERMINATED ·Phase: PHASE3

Clinical Study to Evaluate the Treatment Effect and Safety of BAY1817080 in Patients With Overactive Bladder (OAB)

NCT04545580 ·Status: COMPLETED ·Phase: PHASE2

A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder

NCT03566134 ·Status: COMPLETED ·Phase: PHASE2

Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder.

NCT00561951 ·Status: COMPLETED ·Phase: PHASE2

Study of ONO-8577 in Patients With Overactive Bladder

NCT03106623 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of DA-8010 in Healthy Subjects

NCT02821312 ·Status: UNKNOWN ·Phase: PHASE1

Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive Bladder

NCT00479505 ·Status: COMPLETED ·Phase: PHASE2

A Long-term Study of YM178 in Symptomatic Overactive Bladder Patients

NCT00840645 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder

NCT01868516 ·Status: COMPLETED ·Phase: PHASE2

Phase 1 Study With OAB Assessing the Safety and Activity of hMaxi-K Gene Transfer

NCT01870037 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Intradetrusor AbobotulinumtoxinA and IncobotulinumtoxinA in Women With Overactive Bladder

NCT06250543 ·Status: COMPLETED ·Phase: PHASE4

Exploring Predictors of Symptoms Relapse After Discontinuation of Treatment in Overactive Bladder (OAB) Patients

NCT00730535 ·Status: COMPLETED ·Phase: PHASE4

A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107)

NCT00768521 ·Status: COMPLETED ·Phase: PHASE1

URO-902 in Female Subjects With Overactive Bladder and Urge Urinary Incontinence

NCT04211831 ·Status: COMPLETED ·Phase: PHASE2

Comparative Urine Proteomic Studies of Overactive Bladder in Humans

NCT01367886 ·Status: COMPLETED ·Phase: NA

Effect of Long Acting Anticholinergic on Nocturnal Incontinence After Radical Cystectomy and Orthotopic Neobladder

NCT02877901 ·Status: COMPLETED ·Phase: PHASE2/PHASE3